aa 129-145; partial loop-4+loop-5

General Information


DRACP ID  DRACP04909

Peptide Name   aa 129-145; partial loop-4+loop-5

Sequence  KITRCPMIPCYISSPDE

Sequence Length  17

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic 

Disulfide/Other Bond  Native peptide

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C84H137N21O26S3

Absent amino acids  AFGHLNQVW

Common amino acids  IP

Mass  223888

Pl  6.22

Basic residues  2

Acidic residues  2

Hydrophobic residues  3

Net charge  0

Boman Index  -2584

Hydrophobicity  -20

Aliphatic Index  68.82

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  1615

Absorbance 280nm  100.94

Polar residues  6

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID US20020086420A1

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.